Novartis is committed to improving the accessibility and usability of our websites, ensuring that content and services are available to all visitors, regardless of their ability or the technology they are using.

Our web accessibility efforts are ongoing with the eventual goal of reaching Level AA conformance within the World Wide Web Consortium (W3C) Web Content Accessibility Guidelines (WCAG 2.1).

We welcome feedback which helps improve accessibility of specific pages and our websites overall. To report an accessibility issue, request assistance or ask a question about accessibility please use the form below.

Name (optional)